Endoglycosidase H (Endo H): A Cornerstone Tool for Glycosylation Research and Biopharmaceutical Innovation

1. Concept

Endoglycosidase H (Endo H) is a specialized enzymatic tool that selectively cleaves N-linked oligosaccharides, playing an indispensable role in glycobiology, protein function analysis, and biopharmaceutical development. Initially isolated from Streptomyces plicatus and later optimized via recombinant technology, this enzyme has a molecular weight of approximately 29 kDa, consisting of a single polypeptide chain with a conserved glycosidase catalytic domain.

Its functional core lies in substrate specificity: it specifically hydrolyzes the β-1,4 glycosidic bond within the GlcNAc-GlcNAc core of N-linked oligosaccharides, releasing free oligosaccharide chains while leaving a single GlcNAc residue attached to the asparagine (Asn) of the protein backbone. Endo H exhibits high activity toward high-mannose and hybrid-type glycans but cannot cleave complex-type N-linked glycans containing sialic acid or fucose. It functions optimally at pH 5.5–6.0 and 37°C, with cleavage efficiency influenced by oligosaccharide branching complexity and steric hindrance.

2. Research Frontiers

Recent advancements in Endo H research have focused on expanding its functionality and application scope through technological innovation. A key frontier is enzyme engineering: via directed evolution and rational design, researchers have developed mutants such as Endo H-Fc, which extends substrate specificity to some complex-type oligosaccharides and boosts catalytic efficiency threefold. Another breakthrough is the discovery of homologous enzymes from extremophiles—for example, ThermoEndo H, which tolerates high temperatures (optimal activity at 65°C), enabling industrial-scale oligosaccharide processing under harsh conditions.

AI-assisted enzyme design has emerged as a transformative direction, using deep learning to predict enzyme-substrate binding modes and optimize catalytic sites for enhanced specificity and efficiency. Additionally, the development of multifunctional chimeric enzymes—fusing Endo H with other glycosidases—enables cascade cleavage of diverse oligosaccharide structures, addressing the limitations of single-enzyme systems. These innovations are driving Endo H’s application in precision medicine, industrial biocatalysis, and high-throughput glycoproteomics.

3. Research Significance

Endo H is a linchpin of glycosylation research, with profound implications for basic science and translational applications. In glycobiology, it enables the precise characterization of oligosaccharide structures and glycosylation sites, providing insights into how glycans regulate protein folding, stability, and intercellular signaling. Its ability to differentiate between glycan types (high-mannose vs. complex) makes it invaluable for studying protein transport through the endoplasmic reticulum and Golgi apparatus.

In biopharmaceuticals, Endo H plays a critical role in optimizing recombinant protein drugs. By removing redundant or heterogeneous oligosaccharide chains, it reduces immunogenicity, prolongs in vivo half-life, and improves batch consistency—key factors for drug safety and efficacy. For example, in monoclonal antibody production, Endo H treatment minimizes glycan heterogeneity, enhancing therapeutic performance. In viral research and diagnostics, Endo H simplifies glycoprotein structures, improving mass spectrometry resolution for accurate identification of viral envelope proteins and disease biomarkers.

4. Related Mechanisms, Research Methods, and Product Applications

4.1 Core Catalytic Mechanism

Endo H employs an acid-base catalysis mechanism mediated by conserved Asp-Glu residue pairs in its active center. It specifically recognizes the GlcNAc-GlcNAc core of N-linked high-mannose and hybrid-type glycans, hydrolyzing the β-1,4 glycosidic bond to release oligosaccharide chains. This selective cleavage preserves the protein backbone, enabling downstream structural and functional analysis.

4.2 Key Research Applications

4.2.1 Glycoproteomics Analysis

• Glycosylation Site Identification: Endo H removes high-mannose oligosaccharides to simplify glycoprotein structures, improving mass spectrometry sensitivity for accurate mapping of modification sites.
• Glycan Type Differentiation: Selective cleavage of high-mannose/hybrid glycans enables distinction from complex-type glycans, supporting comprehensive glycan profiling.

4.2.2 Protein Folding and Transport Research

• By comparing protein stability before and after Endo H treatment, researchers can analyze how high-mannose glycosylation influences folding pathways and ER retention.
• Validates protein trafficking through the secretory pathway, as Endo H-sensitive glycoproteins indicate ER localization (unfolded/maturing) while resistant proteins reflect Golgi processing or secretion (mature).

4.2.3 Biopharmaceutical Optimization

• Glycan Homogenization: Reduces oligosaccharide heterogeneity in recombinant proteins (e.g., monoclonal antibodies), improving batch consistency and therapeutic efficacy.
• Immunogenicity Reduction: Removes immunogenic oligosaccharide epitopes, prolonging drug half-life and minimizing adverse immune responses.
• Purification Support: Facilitates glycoprotein purification by simplifying structures for more efficient binding to affinity matrices (e.g., Ni-NTA nano magnetic beads).

4.3 Product Support from ANT BIO PTE. LTD.

ANT BIO PTE. LTD. offers a comprehensive portfolio of Endo H and complementary glycosylation research tools through its UA sub-brand (specializing in recombinant proteins), tailored to meet diverse experimental and industrial needs:

• Recombinant Endo H Variants: Including Endo H (UA070040, expressed in E. coli, $60) and Endo H (MBP Tag, UA070042, $80), providing high-purity, active enzymes for research and biopharmaceutical applications.
• Complementary Glycosidases: Endo F1 (UA070121, $165), Endo S2 (UA070055, $480), and Endoproteinase Glu-C (UA070059, $130) for comprehensive N-linked glycan analysis and protein digestion.
• Glycoprotein Standards: Recombinant Endoglin/CD105 proteins (e.g., UA010868, UA010906) with defined glycosylation patterns, enabling validation of Endo H cleavage efficiency.
• Custom Services: Recombinant protein expression and enzyme engineering services to develop tailored Endo H mutants (e.g., thermostable or substrate-expanded variants) for specialized applications.

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering life science research and translational innovation through the provision of high-quality, reliable reagents and comprehensive solutions. As a leading provider of life science products, our portfolio spans antibodies, recombinant proteins, kits, and general reagents, with three specialized sub-brands catering to distinct research needs: Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins). Our core mission is to accelerate scientific discovery, bridge the gap between basic research and clinical application, and contribute to the advancement of human health by delivering cutting-edge products, professional technical support, and exceptional customer service. We strive to be a trusted partner for researchers and biopharmaceutical developers worldwide, supporting their efforts to unravel glycosylation mysteries and develop innovative therapies.

6. Related Product List (With Product Codes)

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.